When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Zogenix (NASDAQ:ZGNX) announces that The Lancet has published the results of its Phase 3 trial for Fintepla in children and young adults with Dravet syndrome, a rare, catastrophic form of epilepsy.
More news on: Zogenix, Inc., Healthcare stocks news,